BackImmune Therapeutics Overview

Immune Therapeutics Goodwill

Immune Therapeutics's goodwill is $0.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$0.00

Peer trimmed avg / median

Loading

Immune Therapeutics Goodwill History

Loading

Immune Therapeutics vs. peers: Goodwill Comparison

Loading

Immune Therapeutics Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Immune Therapeutics (IMUN) FAQ

The latest goodwill for IMUN is $0 as of June 2024. In the prior-year period, the figure was $0. Investors often review this figure alongside Immune Therapeutics's historical trend and sector peers before judging valuation or financial health.

Over the past year, IMUN's goodwill moved from $0 to $0. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Immune Therapeutics's operating scale or balance-sheet position.

A goodwill figure of $0 for IMUN is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting IMUN's goodwill ($0), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Immune Therapeutics's goodwill against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.